Quidel | QDEL - Interest Expense On Debt


Quidel reported $5.63B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Agilent USD 29M 4M Jun/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Danaher USD 107M 44M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
Illumina USD 24M 2M Mar/2026
IQVIA Holdings USD 197M 5M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Revvity USD 22.99M 1.73M Jun/2026
STAAR Surgical USD 800K 799K Sep/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Waters USD 55M 13M Jun/2026